StockData
Imunon, Inc. logo

Imunon, Inc. (IMNN) stock

IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.58−0.03 (-5.26%)

Close on Nov 18, 2026Market cap $3.25MP/E –Yield –

Imunon shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Imunon's shares outstanding was 5M at Mar 31, 2026. For fiscal 2025 it was 2M, up 93.2% from the year before. Over ten years it grew 43.6% a year on average. The highest annual figure on record is 9M in fiscal 2023.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20252M+93.2%
FY2024Dec 31, 20241M-87.9%
FY2023Dec 31, 20239M+26.6%
FY2022Dec 31, 20227M+31.6%
FY2021Dec 31, 20215M+154.7%
FY2020Dec 31, 20202M+46.4%
FY2019Dec 31, 20191M+24.2%
FY2018Dec 31, 20181M+130.5%
FY2017Dec 31, 20171M+311.4%
FY2016Dec 31, 20160M+116.7%
FY2015Dec 31, 20150M+18.1%
FY2014Dec 31, 20140M+36.4%
FY2013Dec 31, 20130M+75.1%
FY2012Dec 31, 20120M+66.3%
FY2011Dec 31, 20110M+69.0%
FY2010Dec 31, 20100M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2026Mar 31, 20265M+286.5%
Q4 FY2025Dec 31, 20253M+124.4%
Q3 FY2025Sep 30, 20253M+128.2%
Q2 FY2025Jun 30, 20251M+103.8%
Q1 FY2025Mar 31, 20251M-86.2%
Q4 FY2024Dec 31, 20241M-86.1%
Q3 FY2024Sep 30, 20241M-86.2%
Q2 FY2024Jun 30, 20241M-92.8%
Q1 FY2024Mar 31, 20249M+32.4%
Q4 FY2023Dec 31, 20239M+34.7%
Q3 FY2023Sep 30, 20239M+62.5%
Q4 FY2022Dec 31, 20229M+50.8%
Q3 FY2022Sep 30, 20227M+23.0%
Q2 FY2022Jun 30, 20227M+21.9%
Q1 FY2022Mar 31, 20226M+30.6%
Q4 FY2021Dec 31, 20216M+127.7%
Q3 FY2021Sep 30, 20216M+153.7%
Q2 FY2021Jun 30, 20216M+187.5%
Q1 FY2021Mar 31, 20214M+156.9%
Q4 FY2020Dec 31, 20203M+47.7%
Q3 FY2020Sep 30, 20202M+57.5%
Q2 FY2020Jun 30, 20202M+45.0%
Q1 FY2020Mar 31, 20202M+35.1%
Q4 FY2019Dec 31, 20192M+43.2%
Q3 FY2019Sep 30, 20191M+21.7%
Q2 FY2019Jun 30, 20191M+16.1%
Q1 FY2019Mar 31, 20191M+8.0%
Q4 FY2018Dec 31, 20181M+20.0%
Q3 FY2018Sep 30, 20181M+121.0%
Q2 FY2018Jun 30, 20181M+120.3%
Q1 FY2018Mar 31, 20181M+958.5%
Q4 FY2017Dec 31, 20171M+639.5%
Q3 FY2017Sep 30, 20171M+304.1%
Q2 FY2017Jun 30, 20171M+367.4%
Q1 FY2017Mar 31, 20170M+82.1%
Q4 FY2016Dec 31, 20160M–
Q3 FY2016Sep 30, 20160M–
Q2 FY2016Jun 30, 20160M–
Q1 FY2016Mar 31, 20160M–

More Imunon figures

See a number that looks wrong?